Tag: GW Pharmaceuticals

Sentiments for GW Pharma and The Fresh Market rise Pre-Market

GWPH – GW Pharmaceuticals PLC is a biopharmaceutical company specializing in cannabinoid product platform. Its value has surged more than 130% pre-market today.

GWPH – GW Pharmaceuticals PLC

Fundamentals Previously closed at 38.46
Day’s high 38.96
Day’s low  36.55
P/E ratio NA
EPS -3.08


Analysts opinion Analysts are bullish on the stock since GW Pharma announced positive results of Phase 3 investigation of Epidiolex. Epidiolex is a pharmaceutical cannabis (cannabidol) based investigational drug for Dravet syndrome –a progressive disorder characterized by multiple seizure types, often including life-threatening status epilepticus.
Sentiments Reports suggest that 1 in 20 to 1 in 40,000 people have Dravet syndrome. Due to positive news for its cure, the investor sentiments have been bullish.
Social Pulse The stock has 43% higher social chatter than usual.

Continue Reading…